AKT1 and nephrolithiasis: Our study confirms the anti-apoptotic effects of OATF in ex vivo models and identifies the EGFR/PI3K/AKT signaling pathway as a key mechanism, as predicted by network pharmacology, that may influence kidney stone formation.